Xcelerate Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XCRT research report →
Companywww.xcelerate.global
Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. It supplies to controlled clinical care settings, in which developments will be trialed, tested, and applied, as well as provides end-to-end controlled medical technology development.
- CEO
- Michael F. O'Shea
- IPO
- 2001
- Employees
- 12
- HQ
- Coral Springs, FL, US
Price Chart
Valuation
- Market Cap
- $4.32M
- P/E
- -12.32
- P/S
- 2.52
- P/B
- -2.09
- EV/EBITDA
- -22.42
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 29.95%
- Op Margin
- -21.40%
- Net Margin
- -20.47%
- ROE
- 26.53%
- ROIC
- 172.53%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-1,218,458 · -76.91%
- EPS
- $-0.00 · -75.00%
- Op Income
- $-258,816
- FCF YoY
- 51.52%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 1.99
- Avg Volume
- 127.02K
Get TickerSpark's AI analysis on XCRT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our XCRT Coverage
We haven't published any research on XCRT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate XCRT Report →